US Stock MarketDetailed Quotes

ENFN Enfusion

Watchlist
  • 11.110
  • -0.040-0.36%
Close Apr 1 16:00 ET
  • 11.110
  • 0.0000.00%
Post 16:01 ET
1.05BMarket Cap370.33P/E (TTM)

Enfusion Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
35.30%34.68M
46.87%9.67M
33.50%16.16M
21.54%7.31M
65.91%1.53M
81.08%25.63M
-12.43%6.59M
54.37%12.11M
108.24%6.02M
122.55%924K
Net income from continuing operations
-57.69%3.92M
-80.89%172K
-26.46%1.96M
155.21%2.55M
-116.21%-761K
169.77%9.25M
14.21%900K
2.42%2.66M
124.19%998K
137.48%4.69M
Operating gains losses
----
----
----
----
----
--78K
--0
----
----
----
Depreciation and amortization
17.69%11.75M
-7.62%3.25M
17.37%2.96M
37.99%2.87M
43.15%2.67M
57.42%9.99M
107.99%3.52M
48.44%2.52M
28.92%2.08M
39.40%1.87M
Other non cash items
9.22%7.62M
10.35%1.89M
-9.22%1.81M
22.02%2.1M
17.53%1.82M
29.70%6.97M
11.40%1.71M
55.98%2M
-32.85%1.72M
25,766.67%1.55M
Change In working capital
16.63%-7.87M
111.18%321K
266.49%5.59M
-200.13%-4.71M
-39.06%-9.06M
11.77%-9.44M
-243.95%-2.87M
48.64%1.53M
69.58%-1.57M
-13.87%-6.52M
-Change in receivables
-12.72%-4.15M
96.08%-123K
575.38%1.85M
-207.60%-3.16M
-410.02%-2.72M
59.26%-3.68M
-204.73%-3.14M
61.88%-390K
81.99%-1.03M
116.53%878K
-Change in prepaid assets
-173.76%-4.79M
-64.98%-6.23M
2.14%907K
49.61%947K
-181.98%-414K
1.02%-1.75M
5.93%-3.78M
-4.52%888K
-52.37%633K
3,984.62%505K
-Change in payables and accrued expense
158.90%5.17M
9.63%3.69M
49.15%4.55M
-195.80%-388K
44.30%-2.69M
-61.74%2M
135.38%3.37M
25.34%3.05M
-76.87%405K
-1,103.99%-4.83M
-Change in other current assets
----
----
38.52%-233K
-892.22%-713K
0.72%-1.65M
----
----
---379K
--90K
---1.66M
-Change in other current liabilities
31.76%-4.1M
130.73%390K
9.42%-1.49M
16.15%-1.4M
-12.58%-1.59M
-17.43%-6M
-1.44%-1.27M
-25.08%-1.65M
---1.67M
---1.42M
Cash from discontinued investing activities
Operating cash flow
35.30%34.68M
46.87%9.67M
33.50%16.16M
21.54%7.31M
65.91%1.53M
81.08%25.63M
-12.43%6.59M
54.37%12.11M
108.24%6.02M
122.55%924K
Investing cash flow
Cash flow from continuing investing activities
-43.65%-13.89M
-16.03%-2.66M
-6.44%-2.78M
-157.14%-5.71M
-7.76%-2.75M
-21.94%-9.67M
-31.44%-2.3M
-182.75%-2.61M
-6.07%-2.22M
19.58%-2.55M
Capital expenditure reported
-39.08%-7.26M
-62.57%-1.77M
-1.33%-1.67M
-19.96%-1.7M
-99.15%-2.11M
-32.24%-5.22M
---1.09M
---1.65M
---1.42M
---1.06M
Net PPE purchase and sale
18.37%-3.64M
26.06%-891K
-15.24%-1.1M
-25.47%-1.01M
57.35%-635K
-11.74%-4.45M
-154.77%-1.21M
-3.90%-958K
61.71%-801K
53.04%-1.49M
Net other investing changes
---3M
--0
--0
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-43.65%-13.89M
-16.03%-2.66M
-6.44%-2.78M
-157.14%-5.71M
-7.76%-2.75M
-21.94%-9.67M
-31.44%-2.3M
-182.75%-2.61M
-6.07%-2.22M
19.58%-2.55M
Financing cash flow
Cash flow from continuing financing activities
96.74%-1.4M
0
99.74%-14K
99.95%-16K
78.39%-1.37M
-441.31%-43.08M
91.78%-579K
-26,445.00%-5.31M
-33,423.91%-30.84M
-689.19%-6.35M
Net common stock issuance
--0
--0
--0
----
----
--17.32M
--0
--7.63M
----
----
Net other financing activities
97.68%-1.4M
--0
99.89%-14K
99.96%-16K
78.39%-1.37M
-658.95%-60.41M
91.78%-579K
-64,595.00%-12.94M
-43,958.70%-40.53M
-689.19%-6.35M
Cash from discontinued financing activities
Financing cash flow
96.74%-1.4M
--0
99.74%-14K
99.95%-16K
78.39%-1.37M
-441.31%-43.08M
91.78%-579K
-26,445.00%-5.31M
-33,423.91%-30.84M
-689.19%-6.35M
Net cash flow
Beginning cash position
-43.07%35.6M
52.59%48.3M
24.04%34.45M
-39.75%32.89M
-43.07%35.6M
-2.83%62.55M
-50.19%31.65M
-50.90%27.77M
-2.86%54.6M
-2.83%62.55M
Current changes in cash
171.49%19.39M
88.85%7.01M
219.16%13.37M
105.89%1.59M
67.56%-2.59M
-1,464.01%-27.12M
392.98%3.71M
-39.28%4.19M
-3,930.45%-27.04M
1.16%-7.98M
Effect of exchange rate changes
-385.47%-511K
-445.42%-829K
255.02%479K
-118.06%-39K
-481.25%-122K
308.14%179K
-10.78%240K
-467.86%-309K
161.19%216K
137.21%32K
End cash Position
53.02%54.48M
53.02%54.48M
52.59%48.3M
24.04%34.45M
-39.75%32.89M
-43.07%35.6M
-43.07%35.6M
-50.19%31.65M
-50.90%27.77M
-2.86%54.6M
Free cash flow
49.03%23.79M
63.37%7.01M
40.93%13.39M
21.30%4.61M
25.28%-1.22M
156.43%15.96M
-25.70%4.29M
37.27%9.5M
376.07%3.8M
77.63%-1.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 35.30%34.68M46.87%9.67M33.50%16.16M21.54%7.31M65.91%1.53M81.08%25.63M-12.43%6.59M54.37%12.11M108.24%6.02M122.55%924K
Net income from continuing operations -57.69%3.92M-80.89%172K-26.46%1.96M155.21%2.55M-116.21%-761K169.77%9.25M14.21%900K2.42%2.66M124.19%998K137.48%4.69M
Operating gains losses ----------------------78K--0------------
Depreciation and amortization 17.69%11.75M-7.62%3.25M17.37%2.96M37.99%2.87M43.15%2.67M57.42%9.99M107.99%3.52M48.44%2.52M28.92%2.08M39.40%1.87M
Other non cash items 9.22%7.62M10.35%1.89M-9.22%1.81M22.02%2.1M17.53%1.82M29.70%6.97M11.40%1.71M55.98%2M-32.85%1.72M25,766.67%1.55M
Change In working capital 16.63%-7.87M111.18%321K266.49%5.59M-200.13%-4.71M-39.06%-9.06M11.77%-9.44M-243.95%-2.87M48.64%1.53M69.58%-1.57M-13.87%-6.52M
-Change in receivables -12.72%-4.15M96.08%-123K575.38%1.85M-207.60%-3.16M-410.02%-2.72M59.26%-3.68M-204.73%-3.14M61.88%-390K81.99%-1.03M116.53%878K
-Change in prepaid assets -173.76%-4.79M-64.98%-6.23M2.14%907K49.61%947K-181.98%-414K1.02%-1.75M5.93%-3.78M-4.52%888K-52.37%633K3,984.62%505K
-Change in payables and accrued expense 158.90%5.17M9.63%3.69M49.15%4.55M-195.80%-388K44.30%-2.69M-61.74%2M135.38%3.37M25.34%3.05M-76.87%405K-1,103.99%-4.83M
-Change in other current assets --------38.52%-233K-892.22%-713K0.72%-1.65M-----------379K--90K---1.66M
-Change in other current liabilities 31.76%-4.1M130.73%390K9.42%-1.49M16.15%-1.4M-12.58%-1.59M-17.43%-6M-1.44%-1.27M-25.08%-1.65M---1.67M---1.42M
Cash from discontinued investing activities
Operating cash flow 35.30%34.68M46.87%9.67M33.50%16.16M21.54%7.31M65.91%1.53M81.08%25.63M-12.43%6.59M54.37%12.11M108.24%6.02M122.55%924K
Investing cash flow
Cash flow from continuing investing activities -43.65%-13.89M-16.03%-2.66M-6.44%-2.78M-157.14%-5.71M-7.76%-2.75M-21.94%-9.67M-31.44%-2.3M-182.75%-2.61M-6.07%-2.22M19.58%-2.55M
Capital expenditure reported -39.08%-7.26M-62.57%-1.77M-1.33%-1.67M-19.96%-1.7M-99.15%-2.11M-32.24%-5.22M---1.09M---1.65M---1.42M---1.06M
Net PPE purchase and sale 18.37%-3.64M26.06%-891K-15.24%-1.1M-25.47%-1.01M57.35%-635K-11.74%-4.45M-154.77%-1.21M-3.90%-958K61.71%-801K53.04%-1.49M
Net other investing changes ---3M--0--0----------------------------
Cash from discontinued investing activities
Investing cash flow -43.65%-13.89M-16.03%-2.66M-6.44%-2.78M-157.14%-5.71M-7.76%-2.75M-21.94%-9.67M-31.44%-2.3M-182.75%-2.61M-6.07%-2.22M19.58%-2.55M
Financing cash flow
Cash flow from continuing financing activities 96.74%-1.4M099.74%-14K99.95%-16K78.39%-1.37M-441.31%-43.08M91.78%-579K-26,445.00%-5.31M-33,423.91%-30.84M-689.19%-6.35M
Net common stock issuance --0--0--0----------17.32M--0--7.63M--------
Net other financing activities 97.68%-1.4M--099.89%-14K99.96%-16K78.39%-1.37M-658.95%-60.41M91.78%-579K-64,595.00%-12.94M-43,958.70%-40.53M-689.19%-6.35M
Cash from discontinued financing activities
Financing cash flow 96.74%-1.4M--099.74%-14K99.95%-16K78.39%-1.37M-441.31%-43.08M91.78%-579K-26,445.00%-5.31M-33,423.91%-30.84M-689.19%-6.35M
Net cash flow
Beginning cash position -43.07%35.6M52.59%48.3M24.04%34.45M-39.75%32.89M-43.07%35.6M-2.83%62.55M-50.19%31.65M-50.90%27.77M-2.86%54.6M-2.83%62.55M
Current changes in cash 171.49%19.39M88.85%7.01M219.16%13.37M105.89%1.59M67.56%-2.59M-1,464.01%-27.12M392.98%3.71M-39.28%4.19M-3,930.45%-27.04M1.16%-7.98M
Effect of exchange rate changes -385.47%-511K-445.42%-829K255.02%479K-118.06%-39K-481.25%-122K308.14%179K-10.78%240K-467.86%-309K161.19%216K137.21%32K
End cash Position 53.02%54.48M53.02%54.48M52.59%48.3M24.04%34.45M-39.75%32.89M-43.07%35.6M-43.07%35.6M-50.19%31.65M-50.90%27.77M-2.86%54.6M
Free cash flow 49.03%23.79M63.37%7.01M40.93%13.39M21.30%4.61M25.28%-1.22M156.43%15.96M-25.70%4.29M37.27%9.5M376.07%3.8M77.63%-1.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Earnings Season Underway

Earnings season is here. What to know?